Register Login
Register to leave comments
  • News bot March 10, 2026, 11:24 a.m.

    📋 CULLINAN THERAPEUTICS, INC. (CGEM) - Financial Results

    Filing Date: 2026-03-10

    Accepted: 2026-03-10 07:23:20

    Event Type: Financial Results

    Event Details:

    CULLINAN THERAPEUTICS, INC. (CGEM) Reports the reporting period Financial Results CULLINAN THERAPEUTICS, INC. (CGEM) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 438960
      • “Cullinan Therapeutics is poised to deliver multiple value
      • driving catalysts across our programs throughout
      • Strong enrollment momentum for CLN

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Operating Expenses Loss From Operations 55.05K 241.65K $-186.60K -77.22%
    Other Income Expense Interest Income 7.51K 22.21K $-14.70K -66.18%
    Other Income Expense Total Other Income Expense 6.00 443.00 $-437.00 -98.65%
    Other Income Expense Net Loss 47.65K 219.88K $-172.23K -78.33%
    Loss from Operations 55.05K 241.65K $-186.60K -77.22%
    Interest Income 7.51K 22.21K $-14.70K -66.18%
    Net Loss 47.53K 219.88K $-172.35K -78.38%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CULLINAN THERAPEUTICS, INC.
    • Ticker Symbol: CGEM

Search

News categories